Decision Making in a World of Comparative Effectiveness Research

Beschreibung

In the past decade there has been a worldwide evolution in evidence-based medicine that focuses on real-world Comparative Effectiveness Research (CER) to compare the effects of one medical treatment versus another in real world settings. While most of this burgeoning literature has focused on research findings, data and methods, Howard Birnbaum and Paul Greenberg (both of Analysis Group) have edited a book that provides a practical guide to decision making using the results of analysis and interpretation of CER. Decision Making in a World of Comparative Effectiveness contains chapters by senior industry executives, key opinion leaders, accomplished researchers, and leading attorneys involved in resolving disputes in the life sciences industry. The book is aimed at 'users' and 'decision makers' involved in the life sciences industry rather than those doing the actual research. This book appeals to those who commission CER within the life sciences industry (pharmaceutical, biologic, and device manufactures), government (both public and private payers), as well as decision makers of all levels, both in the US and globally. 
In the past decade there has been a worldwide evolution in evidence-based medicine that focuses on real-world Comparative Effectiveness Research (CER) to compare the effects of one medical treatment versus another in real world settings. While most of this burgeoning literature has focused on research findings, data and methods, Howard Birnbaum and Paul Greenberg (both of Analysis Group) have edited a book that provides a practical guide to decision making using the results of analysis and interpretation of CER. Decision Making in a World of Comparative Effectiveness contains chapters by senior industry executives, key opinion leaders, accomplished researchers, and leading attorneys involved in resolving disputes in the life sciences industry. The book is aimed at 'users' and 'decision makers' involved in the life sciences industry rather than those doing the actual research. This book appeals to those who commission CER within the life sciences industry (pharmaceutical, biologic, and device manufacturers), government (both public and private payers), as well as decision makers of all levels, both in the US and globally. 
Unique focus on users of CER Insights from industry decision makers paired with practitioner thought leaders Cutting edge technology applied to fundamental industry/policy challenges Assesses promise and realities of CER: past and future Considers both US and ex-US contexts

Autor*in

Howard G. Birnbaum

Themen in »Decision Making in a World of Comparative Effectiveness Research«

Big Data Comparative Effectiveness Health Economics Health Policy Health Technology Assessment Pharmacoeconomics

Stimmen zu »Decision Making in a World of Comparative Effectiveness Research«

“This ‘Practical Guide’ provides valuable insights on how CER is or can be used by different stakeholders for different types of decisions. … I can highly recommend this thought-provoking collection; it would be of interest to anyone with an interest in how we have gotten to where we are with CER, and how we can best proceed. HEOR researchers and health system stakeholders … would benefit from this wealth of information, insights, and prescriptions.” (Lou Garrison, Value & Outcomes Spotlight, September-October, 2017)

Details

Link teilen